Agile Therapeutics, Inc. entered into a Credit Agreement and Guaranty with Perceptive Credit Holdings III, LP, a related party (Perceptive), for a senior secured term loan credit facility of up to $35.0 million (as amended from time to time, the Perceptive Credit Agreement). On February 9, 2024, the Company and Perceptive entered into an eighth amendment to the Perceptive Credit Agreement (the ?Eighth Amendment?). The Eighth Amendment extends the maturity date of the Perceptive Credit Agreement from February 10, 2024 until March 11, 2024 (the Maturity Date).

As previously disclosed, beginning on December 1, 2023, the Company has been making monthly payments of $150,000 on the outstanding loan balance. Such payments will continue until the Maturity Date, at which time all remaining principal amount outstanding is due.